< 65 years | ≥ 65 years | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Endpoint | Group | HRa | 95% CIb | Pc | HRa | 95% CIb | Pc | |||
All-cause mortality | Cases | No CVD | Ref | 0.020 | Ref | 0.42 | ||||
CVD | 1.22 | 0.96 | 1.55 | 1.44 | 1.20 | 1.73 | ||||
Controls | No CVD | Ref | Ref | |||||||
CVD | 1.79 | 1.43 | 2.24 | 1.59 | 1.37 | 1.83 | ||||
Cancer mortality | Cases | No CVD | Ref | 0.46 | Ref | 0.26 | ||||
CVD | 1.05 | 0.79 | 1.42 | 1.43 | 1.12 | 1.82 | ||||
Controls | No CVD | Ref | Ref | |||||||
CVD | 1.26 | 0.88 | 1.80 | 1.15 | 0.86 | 1.54 |
Endpoint | Group | SHRd | 95% CIb | Pc | SHRd | 95% CIb | Pc | |||
---|---|---|---|---|---|---|---|---|---|---|
Cancer mortality | Cases | No CVD | Ref | 0.52 | Ref | 0.27 | ||||
CVD | 1.02 | 0.75 | 1.39 | 1.31 | 1.02 | 1.68 | ||||
Controls | No CVD | Ref | Ref | |||||||
CVD | 1.19 | 0.83 | 1.71 | 1.06 | 0.80 | 1.42 |